Certara Inc (CERT)

Jan 15, 2025, 7:55 AM EST - 2 days ago

Certara Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results

Jan 10, 2025, 7:14 PM EST - 7 days ago

Final Trade: CERT, XLE, DAL, OKTA

OKTA XLE DAL

Jan 2, 2025, 4:15 PM EST - 15 days ago

Certara to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Dec 2, 2024, 4:15 PM EST - 6 weeks ago

Certara Showcases 2024 Research Wins With Over 100 Papers Published

Nov 6, 2024, 9:09 PM EST - 2 months ago

Certara, Inc. (CERT) Q3 2024 Earnings Conference Call Transcript

Nov 6, 2024, 4:15 PM EST - 2 months ago

Certara Reports Third Quarter 2024 Financial Results

Oct 28, 2024, 4:15 PM EDT - 2 months ago

Certara to Participate in the Stephens Annual Investment Conference

Oct 16, 2024, 4:15 PM EDT - 3 months ago

Certara Appoints John Reynders as New Independent Board Member

Oct 9, 2024, 4:15 PM EDT - 3 months ago

Certara to Report Third Quarter 2024 Financial Results on November 6th, 2024

Oct 2, 2024, 4:15 PM EDT - 3 months ago

Certara Completes Acquisition of Chemaxon

Sep 27, 2024, 6:37 PM EDT - 4 months ago

Final Trade: Certara, Nextera Energy, Knight-Swift Transportation and Lululemon

KNX LULU NEE

Sep 18, 2024, 8:00 AM EDT - 4 months ago

Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug

Aug 21, 2024, 4:15 PM EDT - 5 months ago

Certara to Participate in Upcoming Investor Conferences

Aug 15, 2024, 4:15 PM EDT - 5 months ago

Certara Launches Phoenix™ Version 8.5 Drug Development Software

Aug 6, 2024, 7:36 PM EDT - 5 months ago

Certara, Inc. (CERT) Q2 2024 Earnings Call Transcript

Aug 6, 2024, 4:15 PM EDT - 5 months ago

Certara Reports Second Quarter 2024 Financial Results

Jul 9, 2024, 4:45 PM EDT - 6 months ago

Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio

Jul 2, 2024, 4:15 PM EDT - 7 months ago

Certara to Report Second Quarter 2024 Financial Results on August 6th, 2024

Jun 17, 2024, 8:00 AM EDT - 7 months ago

Certara Launches Next Generation CoAuthor™ Generative AI Regulatory Writing Software

May 29, 2024, 4:15 PM EDT - 8 months ago

Certara to Participate in the Jefferies Global Healthcare Conference

May 21, 2024, 8:00 AM EDT - 8 months ago

Certara Appoints New Chief Human Resources Officer & General Counsel

May 8, 2024, 3:56 AM EDT - 9 months ago

Certara, Inc. (CERT) Q1 2024 Earnings Call Transcript

May 7, 2024, 4:15 PM EDT - 9 months ago

Certara Reports First Quarter 2024 Financial Results

Apr 16, 2024, 8:00 AM EDT - 9 months ago

Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform

Apr 9, 2024, 4:15 PM EDT - 10 months ago

Certara to Report First Quarter 2024 Financial Results on May 7th, 2024 and Participate in the BofA Securities Healthcare Conference

Feb 29, 2024, 9:33 PM EST - 11 months ago

Certara Inc. (CERT) Q4 2023 Earnings Call Transcript

Feb 29, 2024, 4:10 PM EST - 11 months ago

Certara Reports Fourth Quarter 2023 Financial Results

Feb 1, 2024, 4:30 PM EST - 1 year ago

Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference

Jan 30, 2024, 11:44 AM EST - 1 year ago

Certara: Applied BioMath Acquisition And Simcyp Launch Should Drive Growth

Dec 13, 2023, 4:30 PM EST - 1 year ago

Certara Acquires Applied BioMath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies

Nov 21, 2023, 4:30 PM EST - 1 year ago

Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development

Nov 8, 2023, 10:41 PM EST - 1 year ago

Certara Inc. (CERT) Q3 2023 Earnings Call Transcript

Nov 8, 2023, 4:10 PM EST - 1 year ago

Certara Reports Third Quarter 2023 Financial Results

Oct 17, 2023, 2:36 PM EDT - 1 year ago

Circling Back On Certara

Oct 11, 2023, 4:15 PM EDT - 1 year ago

Certara to Report Third Quarter 2023 Financial Results on November 8th, 2023, and participate in the Stephens Annual Investment Conference

Sep 19, 2023, 8:15 AM EDT - 1 year ago

Certara Announces 300th Regulatory Submission Milestone Using its Technology-enabled Services and Software

Aug 29, 2023, 8:15 AM EDT - 1 year ago

Certara Simcyp™ Group Awarded Two New Grants from US FDA

Aug 10, 2023, 7:24 AM EDT - 1 year ago

Certara stock drops after biotech software company misses profit target

Aug 9, 2023, 10:50 PM EDT - 1 year ago

Certara Inc. (CERT) Q2 2023 Earnings Call Transcript

Aug 9, 2023, 4:15 PM EDT - 1 year ago

Certara Reports Second Quarter 2023 Financial Results

Aug 8, 2023, 8:00 AM EDT - 1 year ago

Certara & Xybion Partner to Integrate Nonclinical R&D Software to Streamline Assessing Drug Safety & Efficacy

Aug 3, 2023, 9:00 PM EDT - 1 year ago

Certara collaborates with Korea Institute of Toxicology to ensure FDA submission-ready SEND dataset

Jul 13, 2023, 4:30 PM EDT - 1 year ago

Certara to Report Second Quarter 2023 Financial Results on August 9th, 2023

May 8, 2023, 7:49 PM EDT - 1 year ago

Certara, Inc. (CERT) Q1 2023 Earnings Call Transcript

May 8, 2023, 4:15 PM EDT - 1 year ago

Certara Reports First Quarter 2023 Financial Results

Apr 27, 2023, 8:00 AM EDT - 1 year ago

Certara Customers Received 90 Percent of US FDA Novel Drug Approvals for 9th Consecutive Year

Apr 10, 2023, 4:30 PM EDT - 1 year ago

Certara to Report First Quarter 2023 Financial Results on May 8th, 2023 and Participate in the BofA Securities 2023 Healthcare Conference

Mar 9, 2023, 8:00 AM EST - 2 years ago

A.I. Coming to Certara's D360 Scientific Informatics Software

Mar 7, 2023, 8:00 AM EST - 2 years ago

Certara announces the release of Simcyp™ PBPK Simulator Version 22, expanding ability to simulate untested scenarios for new patient and therapeutic types

Mar 1, 2023, 8:40 PM EST - 2 years ago

Certara, Inc. (CERT) Q4 2022 Earnings Call Transcript